About Kaio Therapy
Kaio Therapy is a Technology company based in Raleigh (United States) founded in 2012. Hyperthermia-based cancer therapeutic platform is developed using nanoparticles. It operates in the Technology and Healthcare sectors. Kaio Therapy has raised $3.91 million across 3 funding rounds. Kaio Therapy offers products and services including IAHT, Nanoparticle Formulation, and AMF Device. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is KAIO Therapy, LLC. Its competitors include Liquidia, Sirnaomics and Acorda; 3 of its 3 listed competitors have raised funding.
Company details
Kaio Therapy was founded in 2012 in Raleigh, United States, within the biotechnology sector focused on oncology. A hyperthermia-based platform is developed, featuring the Immune Activating Heat Therapy device as a drug-device combination. Magnetite Cationic Liposome nanoparticles are injected into tumor sites and exposed to alternating magnetic fields to generate localized heat, aiming to enhance immune responses at the tumor. Operations center on advancing this technology for cancer treatment.
- Headquarters Raleigh, United States
- SectorsTechnologyHealthcare
- Email••••••••
- Website kaiotherapy.com
- Legal Name Kaio Therapy, Llc
- Total Equity Funding$3.91M (USD)
in 3 rounds
- Latest Funding Round$897.2K (USD), Seed
Nov 2020
Products & Services of Kaio Therapy
Kaio Therapy offers a comprehensive portfolio of products and services, including IAHT, Nanoparticle Formulation, and AMF Device.
Uses nanoparticles and magnetic fields to heat and destroy cancer cells
Enables targeted heat delivery for immune activation in tumors
Generates magnetic fields to induce controlled fever in cancer cells
Funding Insights of Kaio Therapy
Kaio Therapy has successfully raised a total of $3.91M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $897.2 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.91M
- Total Rounds 3
- Last Round Seed — $897,204
- First Round $2.81M
(Jan 2014)
All 3 funding rounds of Kaio Therapy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $897,204 | Seed | – | – | – |
| Sep 2016 | $200,000 | Seed | – | – | – |
| Jan 2014 | $2.81M | Seed | – | – | – |
Timeline of Kaio Therapy
3 dated milestones of Kaio Therapy across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Kaio Therapy is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Seed, of $897K.
Competitors of Kaio Therapy
Kaio Therapy has 3 listed competitors in our database, 3 of them funded. They include Liquidia, Sirnaomics and Acorda.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| acorda.com | 1995 | Ardsley, United States | $66.5M | 109 | Engaged in the development and commercialization of therapies that improve neurological function. |
Detailed competitors of Kaio Therapy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nanotechnology
3 companies that operate in the same segment as Kaio Therapy (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kaio Therapy
Kaio Therapy was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Kaio Therapy is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Kaio Therapy is a funded company, having raised a total of $3.91M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.81M, raised on Jan 2014.
Kaio Therapy was founded in 2012 in Raleigh, United States, within the biotechnology sector focused on oncology. A hyperthermia-based platform is developed, featuring the Immune Activating Heat Therapy device as a drug-device combination. Magnetite Cationic Liposome nanoparticles are injected into tumor sites and exposed to alternating magnetic fields to generate localized heat, aiming to enhance immune responses at the tumor. Operations center on advancing this technology for cancer treatment.
Kaio Therapy's top competitors include Sirnaomics, Acorda and Liquidia.
Kaio Therapy offers IAHT, Nanoparticle Formulation, and AMF Device.
Kaio Therapy operates through Kaio Therapy, Llc.